Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 9, 1996, Pages 640-646

  Gronneberg R ^a   Van Hage Hamsten, M ^a   Hallden G ^a   Hed, J ^a   Raud, J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Macroglobulins; Anti lgE; Eosinophils; Histamine; Late cutaneous reaction; Mast cells; Salmeterol; Terbutaline; Wheal and flare reaction; Agonists

Indexed keywords

ALPHA 2 MACROGLOBULIN; HISTAMINE; IMMUNOGLOBULIN E; SALMETEROL; TERBUTALINE;

ADULT; ARTICLE; ATOPY; CLINICAL ARTICLE; HISTAMINE RELEASE; HUMAN; INFORMED CONSENT; POLLEN ALLERGY; PRIORITY JOURNAL; SKIN TEST;

EID: 0029781107     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04684.x     Document Type: Article

References (33)

1. Erjefält I, Persson CGA. Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991;143:1008-14.
2. 2-adrenoceptor agonist, and terbutaline. II. Effect on the late phase reaction. Allergy 1990;45:340-6.
3. Svensjö E. The hamster cheek pouch as a model in microcirculation research. Eur Respir J 1990;3: Suppl 12:595s-601s.
4. 2-adrenoceptor agonist in guinea pig skin. Eur J Pharmacol 1995;272:185-93.
5. Whelan CJ, Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 1992;105:831-8.
6. Whelan CJ, Johnson M, Vardey CJ. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol 1993;110:613-18.
7. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
8. Montefort S, Holgate ST, Howarth PH. Review. Leukocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6:1044-54.
9. 2-adrenergic agonist formoterol. J Appl Physiol 1994;77:397-405.
10. Sanjar S, Aoki S, Boubekeur K, et al. Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br J Pharmacol 1990;99:267-72.
11. Grönneberg R, Zetterström O. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions. Clin Exp Allergy 1992;21:257-63.
12. 2-agonist. J Allergy Clin Immunol 1992;89:844-9.
13. Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993; 48:377-82.
14. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST. Protection against allergen-induced asthma by salmeterol. Lancet 1990;336:1338-42.
15. Wong BJ, Dolovich J, Ramsdale EH, et al. Formoterol compared with beclomethasone and placebo in allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 146:1156-60.
16. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
17. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150: 1006-11.
18. Gratziou C, Roberts JA, Walls A, Holgate ST, Howarth P. Lymphocyte population in BAL of asthmatics after salmeterol treatment [Abstract]. Eur Respir J 1992; Suppl 15:207s.
19. Howarth PH. The investigation of the non-bronchodilator properties of asthma therapies in vivo [Abstract]. Eur Respir J 1991; Suppl 14:399S.
20. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-6.
21. 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 1992; 107:156-60.
22. Niais AT, Ball DI, Butchers PR, et al. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur J Pharmacol 1994;251:127-35.
23. Rabe KF, Giembycz MA, Dent G, Perkins RS, Evans P, Barnes PJ. Salmeterol is a competitive antagonist at β-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. Eur J Pharmacol 1993;231:305-8.
24. Johnson M, Butchers PR, Coleman RA, et al. The pharmacology of salmeterol. Life Sci 1993;52:2131-43.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
26. Raud J, Halldén M, Roquet A, et al. Anti-IgE-induced leukocyte recruitment, mediator release, and albumin extravasation in skin-chamber fluid from healthy and atopic subjects. J Allergy Clin Immunol 1996;97:1151-63.
27. Grönneberg R, Raud J. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare and late induration in human skin. Allergy 1996;51: (In press).
28. Roquet A, Raud J, Halldén G, et al. Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopies. Allergy 1995; 50:414-20.
29. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972;29: Suppl 124:21-37.
30. Halldén G, Hed J. The FOG method. A new approach to detecting activated eosinophils. Allergy Clin Immunol News 1993;5/5:139-43.
31. Hed J, Halldén G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48: Suppl 17:87-93.
32. 2-adrenoceptor agonist, salmeterol. Br J Pharmacol 1993;108:507-15.
33. Taylor DR, Sears MR. Regular beta-adrenergic agonists - evidence, not reassurance, is what is needed. Chest 1994;106:552-9.